We are live on ! Find out more
RCEL icon

Avita Medical

74 hedge funds and large institutions have $57.3M invested in Avita Medical in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital inflows, than outflows

Capital inflows: $11.6M | Capital outflows: $7.76M

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

16% more call options, than puts

Call options by funds: $306K | Put options by funds: $264K

2.1% more ownership

Funds ownership: 24.62% → 26.73% (+2.1%)

1% more funds holding

Funds holding: 73 → 74 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

Holders
74
Holders Change
+1
Holders Change %
+1.37%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
25
Reduced
18
Closed
12
Calls
$306​K
Puts
$264​K
Net Calls
+$42​K
Net Calls Change
-⁠$249​K

RCEL Hedge Fund Activity: Q1 2025 in Review

74 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2025, worth a combined $57.3M — down 31% from $82.6M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new RCEL positions and 12 closed out — a net gain of 1 holder — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $4.11M. The largest seller was Essex Investment Management, exiting entirely with an estimated $3.34M sold.

  • 74 institutional investors held Avita Medical (RCEL) as of Q1 2025, up from 73 in Q4 2024.
  • Funds reported $57.3M of Avita Medical stock for Q1 2025, down 31% quarter-over-quarter.
  • 13 funds opened new Avita Medical positions in Q1 2025 and 12 closed out, a net change of +1 holder.
  • The largest Avita Medical buyer in Q1 2025 was Opaleye Management, an estimated $4.11M added.
  • The largest Avita Medical seller in Q1 2025 was Essex Investment Management, an estimated $3.34M sold.

Based on aggregated 13F filings for Q1 2025.